Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BALANCE-RT
NCT07751159Phase 2Recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jul 2026
- Primary completion
- Jul 2030
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in prostate cancer (PCa) (2 arms), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: International Prostate Symptom Score at 3 months. Started Jul 2026; status: recruiting.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07751159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07751159.